◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › ALGN

Align Technology Inc (ALGN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Supplies · DATA UPDATED 2026-07-19

Align Technology Inc (ALGN) operates in the Health Care Supplies industry and is headquartered in Tempe, United States with about 20,275 employees. Its market capitalization is roughly $12 billion. In the fiscal year ended 2025-12-31, ALGN reported $4.0B in revenue and $410M in net income.

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.

Interactive charts & full statements → Open the ALGN valuation workbench →

ALGN Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$4.1B	$4.0B	$4.0B	$3.9B	$3.7B	$4.0B	$2.5B	$2.4B	$2.0B	$1.5B	$1.1B	$845M	$762M	$660M	$560M	$480M	$387M	$312M	$304M	$284M	$206M
Gross Profit	$2.8B	$2.8B	$2.8B	$2.7B	$2.6B	$2.9B	$1.8B	$1.7B	$1.4B	$1.1B	$815M	$640M	$578M	$498M	$416M	$361M	$303M	$233M	$225M	$209M	$142M
Gross Margin %	67.7%	68.3%	70.0%	70.1%	70.5%	74.3%	71.3%	72.5%	73.6%	75.8%	75.5%	75.7%	75.9%	75.4%	74.4%	75.3%	78.4%	74.8%	74.1%	73.6%	68.6%
Operating Income (EBIT)	$592M	$616M	$608M	$643M	$643M	$976M	$387M	$542M	$467M	$354M	$249M	$189M	$194M	$94M	$86M	$90M	$103M	($34M)	$16M	$34M	($38M)
Operating Margin %	14.4%	15.3%	15.2%	16.7%	17.2%	24.7%	15.7%	22.5%	23.7%	24.0%	23.1%	22.3%	25.4%	14.3%	15.3%	18.8%	26.5%	-10.9%	5.1%	11.9%	-18.2%
Net Income	$430M	$410M	$421M	$445M	$362M	$772M	$1.8B	$443M	$400M	$231M	$190M	$144M	$146M	$64M	$59M	$67M	$74M	($31M)	$80M	$36M	($35M)
Net Margin %	10.5%	10.2%	10.5%	11.5%	9.7%	19.5%	71.8%	18.4%	20.3%	15.7%	17.6%	17.0%	19.1%	9.7%	10.5%	13.9%	19.2%	-10.0%	26.3%	12.6%	-16.9%
EBITDA	$910M	$766M	$817M	$643M	$780M	$1.1B	$481M	$593M	$521M	$391M	$273M	$207M	$211M	$178M	$140M	$108M	$121M	($21M)	$30M	$47M	($27M)
Earnings Per Share (EPS)	$5.97	$5.65	$5.62	$5.81	$4.61	$9.69	$22.41	$5.53	$4.92	$2.83	$2.33	$1.77	$1.77	$0.78	$0.71	$0.83	$0.95	$-0.45	$1.18	$0.50	$-0.55
Shares Outstanding (M)	72M	73M	75M	77M	78M	80M	79M	80M	81M	82M	81M	82M	82M	83M	83M	80M	78M	69M	68M	71M	63M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALGN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$1.0B	$1.0B	$996M	$1.0B	$979M	$995M	$978M	$1.0B
Gross Profit	$737M	$688M	$639M	$708M	$680M	$697M	$682M	$723M
Gross Margin %	70.8%	65.7%	64.2%	69.9%	69.5%	70.0%	69.7%	70.3%
Operating Income (EBIT)	$173M	$160M	$96M	$163M	$131M	$144M	$162M	$147M
Operating Margin %	16.6%	15.2%	9.7%	16.1%	13.4%	14.5%	16.6%	14.3%
Net Income	$113M	$136M	$57M	$125M	$93M	$104M	$116M	$97M
Net Margin %	10.8%	13.0%	5.7%	12.3%	9.5%	10.4%	11.9%	9.4%
EBITDA	$205M	$279M	$212M	$214M	$174M	$215M	$200M	$214M
Earnings Per Share (EPS)	$1.57	$1.89	$0.78	$1.72	$1.27	$1.39	$1.55	$1.28
Shares Outstanding (M)	72M	72M	72M	73M	74M	74M	75M	75M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALGN Free Cash Flow History

Cash flow	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$692M	$593M	$738M	$786M	$569M	$1.2B	$662M	$747M	$555M	$439M	$248M	$238M	$227M	$186M	$134M	$130M	$130M	$74M	$40M	$53M	($14M)
Capital Expenditures (CapEx)	$189M	$102M	$116M	$178M	$292M	$401M	$155M	$150M	$223M	$196M	$71M	$53M	$24M	$19M	$38M	$30M	$18M	$7M	$14M	$7M	$24M
Free Cash Flow (FCF)	$502M	$491M	$623M	$608M	$277M	$771M	$507M	$598M	$331M	$243M	$177M	$185M	$203M	$167M	$95M	$100M	$111M	$67M	$25M	$45M	($38M)
FCF Margin %	12.3%	12.2%	15.6%	15.7%	7.4%	19.5%	20.5%	24.8%	16.9%	16.5%	16.4%	21.8%	26.6%	25.2%	17.0%	20.9%	28.8%	21.4%	8.4%	16.0%	-18.4%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALGN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$151M	$223M	$189M	$129M	$53M	$286M	$264M	$160M
Capital Expenditures (CapEx)	$31M	$67M	$67M	$25M	$25M	$23M	$30M	$53M
Free Cash Flow (FCF)	$120M	$157M	$122M	$103M	$27M	$263M	$234M	$106M
FCF Margin %	11.6%	14.9%	12.3%	10.2%	2.8%	26.4%	23.9%	10.3%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALGN Balance Sheet History

Balance sheet	2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$6.3B	$6.2B	$6.2B	$6.1B	$5.9B	$5.9B	$4.8B	$2.5B	$2.1B	$1.8B	$1.4B	$1.2B	$988M	$832M	$756M	$649M	$477M	$355M	$279M	$223M	$152M
Cash & Cash Equivalents	$1.1B	$1.1B	$1.0B	$937M	$942M	$1.1B	$961M	$550M	$637M	$450M	$389M	$168M	$200M	$243M	$306M	$241M	$295M	$166M	$87M	$89M	$55M
Total Liabilities	$2.2B	$2.2B	$2.4B	$2.5B	$2.3B	$2.3B	$1.6B	$1.2B	$800M	$627M	$401M	$311M	$235M	$198M	$175M	$158M	$99M	$82M	$61M	$62M	$68M
Total Debt (Short + Long-Term)	$33M	$32M	$31M	$30M	$27M	$23M	$22M	$16M	$12M	$18M	$9M	$7M	$7M	$7M	$9M	$73M	$56M	$0M	$0M	$0M	$12M
Total Shareholders' Equity	$4.1B	$4.0B	$3.9B	$3.6B	$3.6B	$3.6B	$3.2B	$1.3B	$1.3B	$1.1B	$995M	$848M	$753M	$634M	$581M	$491M	$378M	$273M	$219M	$161M	$84M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALGN viewer.

Other Companies in Health Care Supplies

WST · West Pharmaceutical Services — $23 billion
COO · Cooper Companies (The) — $14 billion

← ALGM All stocks ALGS →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.